FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Innovations in Care

We provide programs and services that transform the lives of people affected by neuromuscular disease.

On-Demand Webinars

MDA Virtual Learning: Updates in Research and Clinical Care for CMT
Virtual Learning Programs
Presenters: Dr. Steven Scherer
Mar 26, 2024